|
1
|
Tioseco JA, Aly H, Essers J, Patel K and
El-Mohandes AA: Male sex and intraventricular hemorrhage. Pediatr
Crit Care Med. 7:40–44. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
du Plessis AJ and Volpe JJ: Perinatal
brain injury in the preterm and term newborn. Curr Opin Neurol.
15:151–157. 2002.PubMed/NCBI
|
|
3
|
Ivan M, Harris AL, Martelli F and
Kulshreshtha R: Hypoxia response and microRNAs: no longer two
separate worlds. J Cell Mol Med. 12:1426–1431. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chan SY and Loscalzo J: MicroRNA-210: a
unique and pleiotropic hypoxamir. Cell Cycle. 9:1072–1083. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chan SY, Zhang YY, Hemann C, Mahoney CE,
Zweier JL and Loscalzo J: MicroRNA-210 controls mitochondrial
metabolism during hypoxia by repressing the iron-sulfur cluster
assembly proteins ISCU1/2. Cell Metab. 10:273–284. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen Z, Li Y, Zhang H, Huang P and Luthra
R: Hypoxia-regulated microRNA-210 modulates mitochondrial function
and decreases ISCU and COX10 expression. Oncogene. 29:4362–4368.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Favaro E, Ramachandran A, McCormick R, Gee
H, et al: MicroRNA-210 regulates mitochondrial free radical
response to hypoxia and krebs cycle in cancer cells by targeting
iron sulfur cluster protein ISCU. PloS One. 5:e103452010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang X, Ding L, Bennewith KL, Tong RT, et
al: Hypoxia-inducible mir-210 regulates normoxic gene expression
involved in tumor initiation. Mol Cell. 35:856–867. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kushibiki T: Photodynamic therapy induces
microRNA-210 and -296 expression in HeLa cells. J Biophotonics.
3:368–372. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pulkkinen K, Malm T, Turunen M, Koistinaho
J and Yla-Herttualä S: Hypoxia induces microRNA miR-210 in vitro
and in vivo ephrin-A3 and neuronal pentraxin 1 are potentially
regulated by miR-210. FEBS Lett. 582:2397–2401. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bacon AL and Harris AL: Hypoxia-inducible
factors and hypoxic cell death in tumour physiology. Ann Med.
36:530–539. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gordan JD and Simon MC: Hypoxia-inducible
factors: central regulators of the tumor phenotype. Curr Opin Genet
Dev. 17:71–77. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gruber M and Simon MC: Hypoxia-inducible
factors, hypoxia, and tumor angiogenesis. Curr Opin Hematol.
13:169–174. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Harris AL: Hypoxia - a key regulatory
factor in tumour growth. Nat Rev Cancer. 2:38–47. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim JW, Tchernyshyov I, Semenza GL and
Dang CV: HIF-1-mediated expression of pyruvate dehydrogenase
kinase: a metabolic switch required for cellular adaptation to
hypoxia. Cell Metab. 3:177–185. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Koumenis C: ER stress, hypoxia tolerance
and tumor progression. Curr Mol Med. 6:55–69. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qiu J, Zhou XY, Zhou XG, Cheng R, Liu HY
and Li Y: Neuroprotective effects of microRNA-210 against
oxygen-glucose deprivation through inhibition of apoptosis in PC12
cells. Mol Med Rep. 7:1955–1959. 2013.PubMed/NCBI
|
|
18
|
Tabakman R, Lazarovici P and Kohen R:
Neuroprotective effects of carnosine and homocarnosine on
pheochromocytoma PC12 cells exposed to ischemia. Journal Neurosci
Res. 68:463–469. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo G and Bhat NR: p38alpha MAP kinase
mediates hypoxia-induced motor neuron cell death: a potential
target of minocycline’s neuroprotective action. Neurochem Res.
32:2160–2166. 2007.PubMed/NCBI
|
|
20
|
Tabakman R, Jiang H, Schaefer E, Levine RA
and Lazarovici P: Nerve growth factor pretreatment attenuates
oxygen and glucose deprivation-induced c-Jun amino-terminal kinase
1 and stress-activated kinases p38alpha and p38beta activation and
confers neuroprotection in the pheochromocytoma PC12 model. J Mol
Neurosci. 22:237–250. 2004. View Article : Google Scholar
|
|
21
|
Kim J, Krichevsky A, Grad Y, Hayes GD,
Kosik KS, Church GM and Ruvkun G: Identification of many microRNAs
that copurify with polyribosomes in mammalian neurons. Proc Nat
Acad Sci USA. 101:360–365. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kosik KS and Krichevsky AM: The elegance
of the microRNAs: A neuronal perspective. Neuron. 47:779–782. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schratt GM, Tuebing F, Nigh EA, Kane CG,
Sabatini ME, Kiebler M and Greenberg ME: A brain-specific microRNA
regulates dendritic spine development. Nature. 439:283–289. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qiu J, Zhou XY, Zhou XG, Cheng R, Liu HY
and Li Y: Neuroprotective effects of microRNA-210 on
hypoxic-ischemic encephalopathy. Biomed Res Int.
2013:3504192013.PubMed/NCBI
|
|
25
|
Fasanaro P, D’Alessandra Y, Di Stefano V,
Melchionna R, et al: MicroRNA-210 modulates endothelial cell
response to hypoxia and inhibits the receptor tyrosine kinase
ligand Ephrin-A3. J Biol Chem. 283:15878–15883. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Giannakakis A, Sandaltzopoulos R, Greshock
J, Liang S, Huang J, Hasegawa K, Li C, O’Brien-Jenkins A, Katsaros
D, Weber BL, Simon C, Coukos G and Zhang L: miR-210 links hypoxia
with cell cycle regulation and is deleted in human epithelial
ovarian cancer. Cancer Biol Ther. 7:255–264. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
van Rooij E, Liu N and Olson EN: MicroRNAs
flex their muscles. Trends Genet. 24:159–166. 2008.
|
|
28
|
Love TM, Moffett HF and Novina CD: Not
miR-ly small RNAs: big potential for microRNAs in therapy. J
Allergy Clin Immunol. 121:309–319. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Weiler J, Hunziker J and Hall J:
Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs
implicated in human disease? Gene Ther. 13:496–502. 2006.
View Article : Google Scholar
|
|
30
|
Ørom UA, Kauppinen S and Lund AH: LNA
modified oligonucleotides mediate specific inhibition of microRNA
function. Gene. 372:137–141. 2006.PubMed/NCBI
|
|
31
|
Zhang B and Farwell MA: microRNAs: a new
emerging class of players for disease diagnostics and gene therapy.
J Cell Mol Med. 12:3–21. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu NK and Xu XM: MicroRNA in central
nervous system trauma and degenerative disorders. Physiol Genomics.
43:571–580. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang C: Novel functions for small RNA
molecules. Curr Opin Mol Ther. 11:641–651. 2009.PubMed/NCBI
|
